Clinical Trial Update: PRAME Immunohistochemistry-Guided Slow Mohs Micrographic Surgery for the Treatment of Stage 0 to IIc Cutaneous Melanoma [NA]

View source ↗

Summary

An ongoing UC Davis-sponsored clinical trial is evaluating PRAME immunohistochemistry-guided slow Mohs micrographic surgery for stage 0 to II cutaneous melanoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Snippet

Sponsor: University of California, Davis | Conditions: Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | NA | Status: RECRUITING